Axon 1902
CAS [14003-96-4]
MF C11H8O4MW 204.18
Potent and selective IRE1 α inhibitor (IC50: 60 nM). 4μ8C blocks substrate access to the active site of IRE1 and selectively inactivates both Xbp1 splicing and IRE1-mediated mRNA degradation.
KEYWORDS: 4μ8C | Supplier | 14003-96-4 | Axon 1902 | 4mu8C | 4u8C | IRE1 inhibitor | Axon Medchem | Axon1902 | IRE1α | splicing | RNA degradation
BC Cross et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc. Natl. Acad. Sci. USA. 2012, 109(15), E869-78. |
7-hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde
[14003-96-4]
Axon Medchem的业务之一,是独有的Axon Ligands配体库,在世界范围内,被认为是药物研发的标准。这其中,针对850余种生物靶标(包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等),Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库,Axon Medchem还是欧洲著名的CRO公司,主要针对生物活性分子和药物类似分子展开合成及协议开发工作,在过去的10年中,Axon Medchem已经发现了多种潜在药物分子,并在生物医药界享有一定的声誉。